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Abstract We assessed whether increase of subchondral
bone density enhances cartilage stress during impact
loading, leading to progressive cartilage degeneration and
accelerated osteoarthrosis (OA) progression. Sixty-six male
guinea pigs were randomly divided into six groups. During
a 9-week treatment period, four groups received twice-
weekly subcutaneous injections of alendronate (ALN) in
two doses: two groups received 10 lg/kg and two groups
received 50 lg/kg. The two control groups received vehi-
cle. After 9 weeks, one 10 lg/kg ALN group, one 50 lg/kg
ALN group, and one control group were killed. The
remaining three groups (17-week groups) were left for an
additional 8 weeks, receiving the same treatment regimen
before death. The left proximal tibiae were scanned by
micro-computed tomography to quantify the microarchi-
tecture of subchondral bone, followed by mechanical
testing and determination of collagen and mineral. The
control groups had typical OA-related cartilage degenera-
tion at 9 and 17 weeks, whereas the 50 lg/kg ALN group
had even worse degeneration in the medial condyle. It is
unclear whether there is a direct or a secondary effect of
ALN on the cartilage. The 9-week ALN group had
significantly greater subchondral plate thickness. The 9-
and 17-week groups had similar changes of cancellous
bone microarchitecture, with greater volume fraction and
connectivity and an extremely plate-like structure. The 9-
week ALN group had greater bone mineral concentration,
and the 17-week ALN group had reduced collagen con-
centration and greater mineral concentration. Treatment
with ALN did not significantly change the mechanical
properties of the cancellous bone.
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It is now generally recognized that osteoarthrosis (OA) is a
complex multifactorial disease process involving the whole
synovial joint including the articular cartilage, subchondral
bones, synovium, and tendons. Three subchondral miner-
alized tissues, i.e., calcified cartilage, cancellous bone, and
cortical bone, are different in the morphology, physiology,
and mechanical properties and respond to mechanical and
pharmacological stimuli in different ways through pro-
cesses of growth, modeling, and remodeling [1]. It has long
been a subject of debate whether subchondral bone changes
in OA precede, concur with, or follow cartilage degener-
ation. Generally, there are two opposing hypotheses: bone
sclerosis is secondary to cartilage loss and the result of
cartilage breakdown and cartilage degeneration and loss
are secondary to bone sclerosis—the Radin hypothesis. The
Radin hypothesis emphasizes that thickening of subchon-
dral bone increases internal cartilage stress, leading to
increased hardening of the subchondral bone (sclerosis)
and progressive thinning of articular cartilage [2, 3].
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On ethical grounds, it is difficult to obtain tissue samples
from human early-stage OA. Investigations on the earliest
pathological changes have been focused on animal models.
Recent studies have shown that subchondral plate and
subchondral cancellous bone contribute significantly to OA
initiation and progression as an increased subchondral bone
density (volume fraction) results in the overloading and
damage of the cartilage [4, 5]. Thickening of the sub-
chondral plate in macaque monkeys precedes cartilage
fibrillation, which might be due to increased resistance to
compression of the bone [4]. The most fully described
model of knee OA is the Dunkin-Hartley strain guinea pig,
which shares the characteristics of human knee OA and is
biochemically, histologically, and radiologically similar to
human OA. Using this spontaneous OA animal model, we
have currently demonstrated that the subchondral plate is
involved in OA initiation and that subchondral cancellous
bone is affected in both OA initiation and progression in a
primary OA guinea pig model [6]. Furthermore, we have
shown that hyaluronan treatment effectively protects
against cartilage degeneration. Concomitantly, hyaluronan
reduces subchondral bone density and thickness and delays
the change in trabecular structure from rod-like to plate-
like. Thereby, the subchondral bone becomes more com-
pliant and expectedly may reduce cartilage stress during
impact loading [7]. Thus, a more compliant subchondral
bone may have beneficial effects on articular cartilage.
This suggestion could be supported if a less compliant
subchondral bone could be induced and demonstrated to
augment the cartilage degeneration. At present, little is
known about such a worsening, opposite effect of bone
compliance, i.e., increased density and changed microar-
chitecture of subchondral bone on articular cartilage
degeneration in the OA guinea pig model.
Bisphosphonates are potent agents that inhibit bone loss
and increase bone mineralization and have been used
clinically for the treatment of hypercalcemia of malig-
nancy, osteoporosis, Paget’s disease, and bone metastases.
Bisphosphonates have been demonstrated to improve the
three-dimensional (3-D) microarchitecture of cancellous
bone [8], affect cancellous bone apparent modulus [9], and
increase bone density and degree and uniformity of min-
eralization in cancellous bone [10]. However, high-dose
bisphosphonates that inhibit bone remodeling will lead to
microdamage accumulation in bone tissues [11, 12].
The aim of this study was to increase subchondral bone
density and subsequently to examine the effect on cartilage
degeneration in the OA guinea pig model. Specifically, we
investigated the effects of increased bone density by inhi-
bition of bone remodeling using alendronate (ALN) on the
articular cartilage and 3-D microarchitecture and mechan-
ical properties of bone tissues in a primary OA pig model,
rather than assessing a direct or indirect effect of ALN on
cartilage. Thus, we tested the hypothesis that increased




Sixty-six male Charles River strain outbred Dunkin-Hart-
ley guinea pigs were purchased (HB Lidko¨pings
Kaninfarm, Lidko¨ping, Sweden) and used in this study. All
the guinea pigs were acclimated for a period of 2 months
before the experiment was started. The guinea pigs were
housed in environmentally controlled cages, two or three in
each cage. They were fed standard guinea pig chow con-
taining 18% protein, 0.9% calcium, 0.7% phosphorus, and
600 IU/kg vitamin D3 (Altromin Standard Guinea Pig
Chow 3020; Altromin, Lage, Germany). Food and water
were available at all times. The experimental protocol was
in accordance with the Danish Animal Research guidelines
and approved by the Danish Animal Experiment Com-
mittee (study J.nr. 2000/561–329).
Experimental Design
Guinea pigs were randomly divided into six groups with
similar ages and body weights (985–1,061 g). The treat-
ments started in all groups when the guinea pigs were
6.5 months of age. Two groups received ALN 10 lg/kg,
two groups received ALN 50 lg/kg, and two groups
received vehicle (1 mL physiological saline) subcutane-
ously injection twice a week for 9 weeks. At 9 months of
age, one 10 lg/kg group, one 50 lg/kg group, and one
control group (9-week groups, n = 3 9 10) were killed.
The remaining three groups received once more the same
treatment regimen (ALN 10 lg/kg, ALN 50 lg/kg, or
saline injections for an additional 8 weeks). The latter three
groups (17-week groups, n = 3 9 12) were killed when
the animals were 12 months old. Physical well-being and
activity were checked daily, and body weights were mea-
sured weekly. At the completion of the experiment, the
guinea pigs were killed and the left tibiae were dissected
and kept in sealed plastic bags at -20C. The right tibiae
were used in another study.
Micro-Computerized Tomography
The proximal tibiae were scanned using a high-resolution
micro-computerized tomographic (micro-CT) system (lCT
40; Scanco Medical, Bassersdorf, Switzerland) to quantify
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the microarchitecture of the subchondral bone plate. After
this first scan, the proximal tibia was cut 0.5 mm beneath
the subchondral plate and a further cut was made at the
distal part to produce a 3-mm-thick cancellous–cortical
complex bone specimen using a Leitz Microtome 1600
(Ernst Leitz, Wetzlar, Germany). Then, the second scan
was made on this cortical–cancellous bone complex to
quantify the microarchitecture of the subchondral cancel-
lous bone and cortical bone. The scanned images had 3-D
reconstruction cubic voxel sizes of 16 * 16 * 16 lm3
(1,024 9 1,024 pixels) with 16-bit gray levels. The micro-
CT images were segmented using the segmentation tech-
niques described in detail previously [13] with slight
modification [6] to obtain accurate 3-D imaging data sets
for subchondral bone plate, cancellous bone, and cortical
bone [6] (Fig. 1).
3-D Microarchitectural Properties of Subchondral Bone
Plate
The subchondral plate was defined according to the pre-
vious description as beginning from the calcified cartilage–
bone junction and ending at the marrow space [4, 7].
3-D Microarchitectural Properties of Subchondral
Cancellous Bone
Subchondral cancellous bone was defined as the epiphyseal
cancellous bone region 0.5 mm beneath the subchondral
plate. The micro-CT imaging of the cancellous bone was
segmented and separated from the cortical shell. The mi-
croarchitectural properties of the cancellous bone were
calculated using true, unbiased, and assumption-free 3-D
methods [7, 14, 15].
3-D Microarchitectural Properties of Subchondral
Cortical Bone
Subchondral cortical bone was defined as the cortical bone
shell in the region from 0.5 mm beneath the subchondral
plate and 3 mm distally. The micro-CT imaging data of the
cortical bone were segmented and separated from those of
the cancellous bone [7]. The cortical thickness and cross-
sectional area were the mean values obtained for the cor-
tical shell.
Grading Degree of OA
After micro-CT scanning, the sectioned articular cartilage
and subchondral plate complexes from the proximal tibia
were embedded in methylmethacrylate (MMA) and three
slices (8 lm in thickness) from each medial condyle and
lateral condyle were sectioned using a universal heavy-
duty microtome (Reichert-Jung Cambridge Instruments,
Nussloch, Germany). These cartilage slices were stained
with safranin O staining. Then, the degree of cartilage
degeneration was defined and graded according to the
criteria of Mankin et al. [16]. This grading was based on
assessment of the integrity of articular cartilage structure,
loss of staining, and number of chondrocytes and was done
blindly by two persons.
Compression Testing of Proximal Tibiae
Mechanical tests of the proximal tibia 3-mm cancellous–
cortical complex specimens were performed on an 858
Bionix MTS hydraulic material testing machine (MTS
Systems, Minneapolis, MN), using a 1 kN load cell. The
first compression test was performed after 10 precondi-
tioning cycles compressing to 10% strain in the axial
loading direction on the central cancellous bone only, thus
keeping remaining peripheral trabeculae and cortex intact
(reduced platen test) [17]. The second compression test was
then performed on the cortical shell mainly [6]. Mechanical
Subchondral 
bone plate
Cortical shell        
test on cortical bone mainly  test on cancellous bone only
Cortical-cancellous
specimen
2. Compression mechanical test
1. Micro-CT scanning & Microarchitecture
Cancellous bone
Fig. 1 Study protocol. The proximal 4 mm of tibiae were scanned by
micro-CT for quantification of 3-D microarchitecture of the sub-
chondral bone plate. Then, a 3-mm-thick cancellous–cortical bone
complex specimen was produced 0.5 mm beneath the subchondral
plate. This complex specimen was scanned by micro-CT to quantify
the microarchitecture of subchondral cancellous and cortical bones.
The reduced platen test was first performed on cancellous bone only,
then the compression test was done on the remaining cortical bone to
determine their mechanical properties (see text) [6]
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properties were calculated from stress–strain curves
derived from the recorded load-deformation curves [18].
The cross-sectional area used for normalization was, for
trabecular bone, the contact area of the testing column and,
for cortical bone, the mean cross-sectional area of the
proximal and distal ends of the specimen (measured from
micro-CT images) minus the contact areas of the testing
columns for the reduced platen test (6) (Fig. 1).
Determination of Bone Density, Collagen, and Mineral
After mechanical testing, the 3-mm-thick specimen was
defatted. Thereafter, the dry weight and submerged weight
(based on Archimedes’ principle) of the specimens were
measured (Mettler AT250 Delta Range balance; Mettler-
Toledo, Greifensee, Switzerland) [18]. The determination
of dry weight and submerged weight was repeated once.
The total bone volumes of the specimens were determined
from micro-CT images. Bone tissue density (g/cm3) and
apparent density (g/cm3) of the specimens were calculated
[18]. Then, the specimens were sectioned into medial and
lateral condyle subspecimens. Two pieces from each con-
dyle, after determination of the dry weight of the pieces,
were used for collagen and mineral determinations
according to a previously described procedure [18]. Thus,
collagen content was estimated by measuring hydroxy-
proline, assuming a content of hydroxyproline in collagen
of 13.4% (w/w). Hydroxyproline was determined by a
colorimetric assay after hydrolysis of bone pieces. Mineral
was estimated after incineration of the bone pieces in a
muffle oven and determination of dry weight of the ash.
Collagen and mineral contents were normalized with the
dry weight of the bone pieces to derive collagen and
mineral percentages and the collagen/mineral ratio.
Statistical Analysis
The results (mean with standard deviation [SD]) were ana-
lyzed statistically using SPSS version 10.0.7 software (SPSS
Inc., Chicago, IL). Normality and equal variance of the data
were examined first. One-way analyses of variance
(ANOVA) were performed among the three groups in each of
the two experimental periods, and post-hoc multiple com-
parisons were adjusted using the Bonferroni test or Dunnett’s
test as appropriate. P \ 0.05 was considered significant.
Results
At death, the mean body weights (1,116–1,177 g) and the
mean body weight gain (90–191 g) did not differ between
the six groups.
Progressive cartilage degeneration was seen in both
condyles of the guinea pigs (Fig. 2). Both 9- and 12-
month-old guinea pigs developed typical osteopathy that
was similar to human OA. Thus, chondrocyte death and
proteoglycan loss with cartilage fibrillation were seen on
the medial tibial plateau in all six groups. Incidence and
severity of the cartilage lesions increased with age, and at
12 months of age the control animals had moderate
degeneration in both the medial and lateral tibial condylar
cartilage. Interestingly, the ALN-treated groups had more
severe cartilage degeneration in the medial condyle and in
the lateral condyle in the 9-week groups compared with
controls (Fig. 2).
The 3-D reconstruction of proximal tibial subchondral
bone tissues is demonstrated in Figure 3. Significant
Fig. 2 Mankin score for medial and lateral condylar cartilage.
Subchondral bone plate thickness. Mean and SD (vertical bar).
One-way ANOVA was performed among the three 9-week groups
and the three17-week groups, and the resulting P values are indicated.
*P \ 0.05 when 10 lg and 50 lg ALN groups were compared with
controls (C) of the same age (post-hoc multiple comparisons)
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microarchitectural changes by inhibition of bone remod-
eling with ALN can be observed. In the 9-week groups, the
50 lg/kg ALN treatment resulted in significantly increased
lateral subchondral bone plate thickness compared with
controls (Fig. 4). In the control groups, an age-related
increment in the plate thickness to a higher level was
apparent in the 17-week group. However, ALN treatment
did not increase the plate thickness above this higher level
of the 17-week control group.
One of the most striking features after ALN treatment
was microarchitectural changes in the subchondral can-
cellous bone (Table 1, Fig. 5). Thus, ALN treatment
resulted in significantly increased cancellous bone volume
fraction, connectivity density, and bone surface density. In
addition, the trabeculae became more plate-like in structure
(reduced structure model index) with reduced preferential
orientation (architectural anisotropy) and separation. The
changes in trabecular bone appeared after 9 weeks of
treatment, with only a minor dose response of the doses
given, and prolonged ALN treatment did not accentuate the
difference between the ALN-treated groups and controls.
The most outstanding changes in the 3-D microarchi-
tecture of subchondral cortical bone following ALN
treatment were a greater cortical thickness and cross-sec-
tional area, with an effect of ALN that appeared to increase
with both ALN dose and treatment period (Fig. 6).
ALN treatment induced compositional changes in the
subchondral bone (Table 2). Thus, following ALN treat-
ment, the collagen concentration was reduced and the
mineral concentration was increased. These changes were
mirrored in a reduced collagen/mineral ratio and an
increased tissue density. Also, the apparent density
Fig. 3 3-D reconstruction of
proximal tibial subchondral
bone tissues from micro-CT
imaging. Significant
microarchitectural changes by
inhibition of bone remodeling
with ALN can be observed.
These changes are supported by
alteration of microarchitectural
parameters; e.g., in all the ALN
groups, bone density was
increased, with more densely
packed and extremely plate-like
trabeculae and thicker cortex.
MS, Mankin score
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increased. These changes appeared more pronounced after
17 weeks of treatment but were minimally influenced by
ALN dose.
Treatment with ALN did not significantly influence the
normalized mechanical properties of cancellous bone
(Fig. 7). In cortical bone, high-dose ALN treatment
increased ultimate stress in both the 9- and 17-week groups
(Fig. 7). In addition, both doses of ALN either tended to (in
the 9-week groups) or were found to (in the 17-week
groups) increase failure energy. Low-dose ALN treatment
increased ultimate strain in the 9-week and, more mark-
edly, in the 17-week groups.
Discussion
The present results on proximal tibia demonstrate ALN
treatment–induced increments in subchondral cancellous
and cortical bone volumes. In addition, pronounced mi-
croarchitectural changes of cancellous bone, increased
densities and mineralization of subchondral bone, and
elevated normalized ultimate stress of the subchondral
cortical bone shell were found. All these changes to some
extent were accompanied by increased articular cartilage
degeneration (Mankin score). However, subchondral plate
thickness was found to be significantly increased only in
the lateral condyle in the 9-week group treated with 50 lg
ALN/kg. Though the present results indicate accumulation
of subchondral bone following ALN treatment, this accu-
mulation is not followed by significant changes in elastic
properties (Young’s modulus) of the subchondral bone.
Therefore, these data only partially support the hypothesis
that increased subchondral bone density leads to significant
articular cartilage damage.
In this study, ALN was given in two doses, 10 lg/kg
and 50 lg/kg twice a week, which were estimated to rep-
resent similar and fivefold the clinical dose, respectively.
These doses appear to have a dose-dependent antiresorp-
tive effect on both cancellous and cortical bone as evident
from the increases in cancellous bone volume fraction and
in cortical thickness and cross-sectional area. We previ-
ously demonstrated that 6-month-old male guinea pigs had
initiated OA, 9-month-old guinea pigs had typical OA, and
12-month-old guinea pigs had severe OA [6]. This study
was initiated when the guinea pigs were 6.5 months old.
Thus, when the guinea pigs were killed at 9 months or
12 months, typical OA or severe OA had developed in the
control groups [6]. Dunkin-Hartley guinea pigs develop
Fig. 4 Thickness of medial and lateral subchondral plate. *P \ 0.05
when 10 lg and 50 lg ALN groups were compared with controls (C)
of the same age (post-hoc multiple comparisons)
Table 1 3-D microarchitectural properties of subchondral cancellous bone
9-week experimental period 17-week experimental period
Control 10 lg ALN 50 lg ALN ANOVA P Control 10 lg ALN 50 lg ALN ANOVA P
Trabecular thickness (lm) 134 ± 12 128 ± 24 153 ± 42 0.14 145 ± 12 151 ± 47 140 ± 23 0.72
Architecture anisotropy (–) 1.83 ± 0.08 1.64 ± 0.09* 1.64 ± 0.08* \0.001 1.67 ± 0.13 1.64 ± 0.07 1.67 ± 0.06 0.58
Bone surface density (mm-1) 5.78 ± 0.95 8.05 ± 1.20* 7.39 ± 0.84* \0.001 6.79 ± 0.35 8.02 ± 1.29* 7.67 ± 0.53 0.007
Trabecular separation (lm) 367 ± 97 214 ± 65* 204 ± 50* \0.001 267 ± 27 192 ± 26* 217 ± 34* \0.001
Mean ± SD. The resulting P values obtained by one-way ANOVA are given
*P \ 0.05 compared with control of the same age (post-hoc multiple comparisons)
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primary OA at an early age, much earlier than that at which
humans do [19, 20]. During the experimental period the
guinea pigs gained weight. This weight gain occurred from
6.5 to 9 months of age since the weights of the six groups
(9 and 12 months old) were very similar at death. This
growth may accelerate OA progression [6]. However, ALN
treatment accelerated OA progression to a great extent.
In a previous study on cynomolgus macaques, OA-
increased subchondral plate thickness was directly associ-
ated with increased severity of cartilage lesions in the knee
joint and animals with low subchondral plate thickness did
not have cartilage lesions [4]. In the present study, the
association between subchondral plate thickness (Fig. 4)
and Mankin score (Fig. 1) appears not to be unequivocal.
Thus, in the medial condyle, the subchondral plate thick-
ness was not found to be different in any of the treatment
periods, whereas the Mankin score increased with the ALN
dose in both treatment periods. Truly, in the lateral con-
dyle, both thickness and Mankin score either showed some
coordinated increments (in the 9-week groups) or were not
found to be different (in the 17-week groups) upon ALN
treatment. Conflicting results for the association between
subchondral plate thickness and Mankin score were also
apparent in a previous study [7], where hyaluronan treat-
ment for 2.5 and 5.5 months was associated with nearly
absent cartilage degeneration after both treatment periods
but with a reduced and an unchanged plate thickness,
Fig. 5 Subchondral cancellous bone volume fraction, structure
model index, and connectivity density. *P \ 0.05 when 10 lg and
50 lg ALN groups were compared with controls (C) of the same age
(post-hoc multiple comparisons)
Fig. 6 Thickness and cross-sectional area of the subchondral cortical
bone shell. *P \ 0.05 when 10 lg and 50 lg ALN groups were
compared with controls (C) of the same age (post-hoc multiple
comparisons)
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respectively, compared to controls [7]. Therefore, the
association between subchondral plate thickness and car-
tilage degeneration does not seem straightforward in the
OA guinea pig model [6, 7].
ALN treatment dramatically changed the microarchitec-
ture of the subchondral cancellous bone in both the 9- and 17-
week groups. Thus, ALN increased cancellous bone volume
fraction, changed trabecular structure to extremely plate-
like, decreased architectural anisotropy, and increased con-
nectivity density (Table 1, Fig. 5). High-dose ALN
treatment for 1 year was previously found to cause a sig-
nificant increase in the mechanical properties of normal
cancellous bone through microarchitectural adaptation [8],
despite large accumulation of microdamage [12]. However,
in this OA model, the changes in microarchitecture may have
great significance. Thus, it has been well documented that
bone strength depends on bone volume, microarchitecture,
degree of mineralization, and bone remodeling [21]. The
observed increased cancellous bone volume fraction,
increased mineral concentration in the subchondral cortical–
cancellous bone (Table 2), and change to plate-like trabec-
ulae upon ALN treatment are all suggested to contribute to a
higher mechanical stress [6]. However, the concomitant
reduction in architectural anisotropy, i.e., reduction in axial
trabecular orientation (which was significant in the 9-week
groups), may be the reason for the insignificant increase in
ultimate stress and Young’s modulus of cancellous bone in
the axial direction (Fig. 7). Also, the accumulation of mi-
crodamage in consequence of suppressed bone turnover by
bisphosphonates [11, 12] may negatively influence
mechanical strength. Taken together, the fact that the
increased total amount of bone volume could not show
parallel increased mechanical properties is likely due to
deterioration of OA subchondral bone quality [5].
The present study showed that ALN treatment resulted
in significantly greater thickness and cross-sectional area of
the subchondral cortical shell, with the most marked
changes after 17 weeks of treatment (Fig. 6). The accretion
of cortical bone clearly indicates that bone formation pre-
vails over bone resorption and thereby confirms the effect
of ALN at the doses given. The increased cortical bone
mass was accompanied by enhanced mechanical properties
of the cortical bone (Fig. 7). This finding indicates that the
cortical bone material added during the ALN treatment
period has higher mechanical properties. The higher con-
tent of mineral, the increased tissue density, and the
reduced collagen/mineral ratio in the subchondral cortical–
cancellous specimen (Table 2) could be the explanation for
this increment in mechanical properties. Thus, in cortical
bone of normal female rats, an age-related decreasing
collagen/mineral ratio and an increasing tissue density are
coincidental with an increasing ultimate stress [22]. The
importance of the cortical shell in OA progression is not
known and has attracted little attention. However, the
subchondral bone plate has a thickness similar to the cor-
tical shell, and the thickness of the plate is influenced to
some extent by ALN treatment. It could be speculated
whether the mechanical properties of the cortical shell also
are valid for the subchondral plate. Information about these
properties, still to be obtained, in combination with those of
the underlying cancellous bone could contribute to a better
understanding of the total subchondral mechanical energy
absorption capacity and the impact loading of the articular
cartilage.
Besides an increased ultimate stress of the cortical shell
following ALN treatment, the ultimate strain increased too
(low-dose ALN). This change in ultimate strain could
explain the absence of an increase in Young’s modulus,
which did not show significant changes. In addition, the
mechanical properties of subchondral cancellous bone
were not significantly changed. Therefore, any change in
compliance of the subchondral bone and in the impact
loading of the articular cartilage following ALN treatment
is not unequivocally substantiated in the present study.
Recent studies have revealed that accelerated subchon-
dral bone turnover is accompanied by specific structural
changes in the cancellous bone of OA joints [23], abnormal
bone mineral content [24, 25], and severalfold increased
subchondral bone collagen metabolism in human femoral
heads [25]. Whether subchondral changes exacerbate or
Table 2 Collagen and mineral composition and density of subchondral bone tissue
9-week experimental period 17-week experimental period
Control 10 lg ALN 50 lg ALN ANOVA P Control 10 lg ALN 50 lg ALN ANOVA P
Collagen concentration (%) 17.2 ± 2.1 16.6 ± 2.3 17.4 ± 1.3 0.59 19.4 ± 1.8 16.8 ± 1.9* 17.4 ± 1.4* 0.004
Mineral concentration (%) 67.3 ± 2.7 69.8 ± 1.1* 69.7 ± 2.1* 0.01 66.9 ± 1.9 70.0 ± 1.6* 71.2 ± 1.0* \0.001
Collagen/mineral ratio 0.26 ± 0.03 0.24 ± 0.03 0.25 ± 0.02 0.25 0.29 ± 0.03 0.24 ± 0.03* 0.25 ± 0.02* \0.001
Tissue density (g/cm3) 2.30 ± 0.08 2.32 ± 0.01 2.32 ± 0.02 0.35 2.16 ± 0.06 2.33 ± 0.02* 2.35 ± 0.02* \0.001
Apparent density (g/cm3) 0.86 ± 0.10 0.98 ± 0.09 1.08 ± 0.14* \0.001 0.94 ± 0.16 1.12 ± 0.13* 1.12 ± 0.12* 0.007
Mean ± SD. The resulting P values obtained by one-way ANOVA are given
*P \ 0.05 compared with control of the same age (post-hoc multiple comparisons)
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precede articular cartilage damage or vice versa in OA has
been controversial and remains a subject of debate [26].
Hayami et al. [27] reported that ALN suppressed sub-
chondral bone remodeling and was chondroprotective in a
rat anterior cruciate ligament transection (ACLT) model of
OA. However, the secondary OA, e.g., posttraumatic car-
tilage lesion, has a typical subchondral bone volume
pattern with markedly decreased bone volume due to dis-
use right after the ACLT. However, in primary OA, the
bone volume pattern is different with no temporary early
drop in bone volume. Furthermore, the chondroprotective
effect and the inhibitory effect on bone formation in the
later phase of ALN as found by Hayami et al. [27] are not
shown in the guinea pig model with primary OA in the
present study.
It remains to be shown whether the subchondral bone
changes and the articular cartilage degeneration in OA are
mechanically coupled processes, metabolically coupled
Fig. 7 Ultimate stress of
subchondral cancellous bone
and subchondral cortical bone
shell. *P \ 0.05 when 10 lg
and 50 lg ALN groups were
compared with controls (C) of
the same age (post-hoc multiple
comparisons)
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processes, or coincidental processes mediated by growth
factors/cytokines from other tissues (synovial membrane,
capsule, ligaments, muscles, etc.) that are involved in the
joint movements. To what extent ALN directly may affect
chondrocytes or the cells in the other tissues is, at present,
unknown. This issue was not investigated in the current
study. We emphasize that the current investigation focused
on the effects of ALN-inhibited remodeling of subchondral
bone and we did not explore any potential effects of ALN
on cartilage.
In conclusion, inhibition of bone remodeling by ALN
significantly increased the subchondral bone mass, greatly
changed the microarchitecture, and increased the bone
mineral content and density. Furthermore, accelerated
articular cartilage degeneration was observed at the medial
condyle and, to some extent, at the lateral condyle. The
mechanical properties increased significantly only for the
subchondral cortical bone. Thus, the present results suggest
that increased subchondral bone density promotes OA
progression and call for circumspection in using bone
density–enhancing drugs for intervention of primary OA.
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